New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD
New phase 3 analyses show centanafadine improves adult ADHD executive function and emotional regulation beyond core symptoms, as FDA review advances toward July 2026.
Other Articles in this Edition
Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD
Slow Maternal Response Time Linked to ADHD in Kids
Five common medications that make it harder to cope in a heatwave
How Can I Explain My Adult ADHD to People I Know?
Genetic markers for ADHD influence early toddler activity levels
Exploring Canine-Assisted Interactions for Children with ADHD
Student-led research explores how music affects learning for students with ADHD
Psychedelics not yet ready for clinical use in ADHD treatment, study finds
Student with ADHD and autism proves what’s possible with the right support
New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD